Melanóma: vizsgálatok itt: Spanyolország
50 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 2. fázisTaking peoplePhase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00 - 2. fázisTaking peoplePhase II study of Roginolisib in UM patients
- Where
- L'Hospitalet de Llobregat, Madrid, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- iOnctura SA
See details and how to join2024-514333-37-00 - 3. fázisTaking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Barcelona, Madrid, Murcia, Pamplona
- Életkor
- 12 év and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - 3. fázisTaking peopleAdjuvant Tebentafusp in High Risk Ocular Melanoma
- Where
- L'Hospitalet de Llobregat, Madrid, Valladolid
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00 - 3. fázisTaking peopleRandomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)
- Where
- Barcelona, Bilbao, Huelva, Lleida, Madrid, Málaga, Sabadell, Sevilla, Torrejón de Ardoz
- Életkor
- 18 év and over
- People
- 119 worldwide
- Run by
- Mabxience Research S.L.
See details and how to join2025-521562-95-00 - 3. fázisTaking peopleNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- L'hospitalet De Llobregat, Pamplona, Santiago de Compostela, Sevilla, Valladolid
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00 - 1/2. fázisNot yet taking people in SpanyolországA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Where
- Barcelona, Madrid, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00 - 1. fázisFut, nem toborozA Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma
- Where
- Badalona, Barcelona, Cáceres, Madrid, Málaga, Sabadell, Santander, Torrejón de Ardoz
- Életkor
- 18 év and over
- People
- 83 worldwide
- Run by
- Celltrion Inc.
See details and how to join2023-510017-26-00 - 2/3. fázisNot yet taking people in SpanyolországA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Where
- L'Hospitalet de Llobregat
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00 - 3. fázisTaking peopleTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Where
- Barcelona, Madrid, Málaga, Valencia
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00 - 3. fázisTaking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- A Coruña, Barcelona, Córdoba, El Palmar, Granada, Las Palmas de Gran Canaria, Madrid, Málaga, Pamplona, Reus, San Sebastián, Santander, Seville, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314 - 1. fázisTaking peopleA Study to Evaluate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of Xdivane versus Opdivo® in Patients with Resected Melanoma
- Where
- Badajoz, Barcelona, Cáceres, Madrid, Málaga
- Életkor
- 18 év and over
- People
- 34 worldwide
- Run by
- Intas Pharmaceuticals Limited
See details and how to join2025-522307-14-00 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - 3. fázisTaking peopleEfficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Where
- Badalona, Barcelona, Donostia, Las Palmas De Gran Canaria, Madrid, Málaga, Murcia, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT03567889 · EU 2023-507119-36-00 - No phaseNot yet taking people in SpanyolországNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Seville
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759 - 2. fázisTaking peopleEncorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
- Where
- A Coruña, Almería, Barcelona, Burgos, Cáceres, Donostia, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Murcia, Santander, Sevilla, Toledo, Valencia, Valladolid
- Életkor
- 18 év and over
- People
- 33
- Run by
- Grupo Español Multidisciplinar de Melanoma
See details and how to joinNCT06887088 · EU 2024-513375-40-00 - No phaseTaking peopleResistance Exercise in Patients With Ocular Melanoma
- Where
- Valencia
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Valencia
See details and how to joinNCT06970236 - No phaseTaking peoplePrecision Medicine for L/GCMN and Melanoma 1
- Where
- Barcelona
- People
- 6000
- Run by
- Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT06608420 - No phaseTaking peopleUnderstanding the Transition from Normal Melanocytes to Nevus to Melanoma
- Where
- Barcelona
- People
- 100 worldwide
- Run by
- Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT06605417 - No phaseTaking peoplePrecision Medicine for L/GCMN and Melanoma 2
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT06605443 - 2. fázisTaking peopleEvaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 40
- Run by
- Vall d'Hebron Institute of Oncology
See details and how to joinNCT06630611 - No phaseTaking peopleThe 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
- Where
- Zaragoza
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT06685562 - No phaseTaking peopleArtificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
- Where
- Barcelona
- People
- 3000 worldwide
- Run by
- German Cancer Research Center
See details and how to joinNCT06621810 - 2. fázisTaking peoplePhase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- IO Biotech
See details and how to joinNCT05280314 - No phaseTaking peopleSpanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Las Palmas, León, Madrid, Oviedo, Palma de Mallorca, Pontevedra, Santa Cruz de Tenerife, Seville, Valencia, Zaragoza
- People
- 7000
- Run by
- Fundación Academia Española de Dermatología
See details and how to joinNCT05673681